Danaher (DHR) Higher, Sees Q4 EPS Exceeding Previous Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St futures slip as yields and oil rebound; Fed minutes in focus
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts DHR Hot Sheet
Price: $215.61 --0%
Revenue Growth %: +8.3%
Financial Fact:
Interest income: 100K
Today's EPS Names:
AEHR, VFS, CMTL, More
Revenue Growth %: +8.3%
Financial Fact:
Interest income: 100K
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
Danaher Corporation (NYSE: DHR) shares have been higher all session following a regulatory filing earlier.
The company said CEO H. Lawrence Culp, Jr., will be presenting at the J.P. Morgan Healthcare Conference today and it expects to exceed the high-end of previous fourth-quarter 2012 EPS guidance.
Shares are up 3.6 percent on the session.
The full release is below.
Danaher Corporation announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company’s performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company’s fourth quarter 2012 diluted net earnings per share is anticipated to be above the high end of the previously announced range of $0.80-0.85, with higher than expected core revenue growth in the quarter.
*** The Street consensus calls for Q412 EPS of $0.83.
Mr. Culp stated: “We are pleased by the strong finish to the year from both a revenue and earnings perspective, which was broad-based across most of our businesses.”
The company said CEO H. Lawrence Culp, Jr., will be presenting at the J.P. Morgan Healthcare Conference today and it expects to exceed the high-end of previous fourth-quarter 2012 EPS guidance.
Shares are up 3.6 percent on the session.
The full release is below.
Danaher Corporation announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company’s performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company’s fourth quarter 2012 diluted net earnings per share is anticipated to be above the high end of the previously announced range of $0.80-0.85, with higher than expected core revenue growth in the quarter.
*** The Street consensus calls for Q412 EPS of $0.83.
Mr. Culp stated: “We are pleased by the strong finish to the year from both a revenue and earnings perspective, which was broad-based across most of our businesses.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises TSMC price target to NT$4,000, keeps Buy rating
- Cantor Fitzgerald Upgrades Humana (HUM) to Overweight, 'A Strong 2027 Margin Year Bridges to an Inexpensive 2028 Multiple'
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
Create E-mail Alert Related Categories
Guidance, Insiders' BlogRelated Entities
JPMorgan, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
